Two Cases of Takotsubo Cardiomyopathy During Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment for Rare Non-small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutation-Reference-Cited by-同舟云学术

Two Cases of Takotsubo Cardiomyopathy During Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment for Rare Non-small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutation

Published:2024-06-20 Issue:3 Volume:64 Page:200-205
ISSN:0386-9628
Container-title:Haigan
language:en
Short-container-title:JJLC

Author:

Tanaka Satoshi¹,Yagi Ryota²,Yoshimura Nobuaki¹,Asakawa Ryo¹,Tobita Satoshi¹,Yaga Moto¹,Ueno Kiyonobu¹

Affiliation:

1. Department of Respiratory Medicine, Osaka General Medical Center

2. Division of Cardiology, Osaka General Medical Center

Publisher

Japan Lung Cancer Society

Link

https://www.jstage.jst.go.jp/article/haigan/64/3/64_200/_pdf

Reference15 articles.

1. 1. 日本肺癌学会, 編集. 肺癌診療ガイドライン2023年版.

2. 2. 佐藤光, 立石博信, 内田俊明, 土手慶五, 石原正治. 多枝spasmにより特異な左心室造影「ツボ型」を示したstunned myocardium. 児玉和久, 土師一夫, 堀正二, 編集. 臨床からみた心筋細胞障害: 虚血から心不全まで. 東京: 科学評論社; 1990: 56-64.

3. 3. Joy PS, Guddati AK, Shapira I. Outcomes of Takotsubo cardiomyopathy in hospitalized cancer patients. J Cancer Res Clin Oncol. 2018; 144: 1539-1545.

4. 4. 日本臨床腫瘍学会, 日本腫瘍循環器学会, 編集. Onco-cardiologyガイドライン. 東京: 南江堂; 2023: 23.

5. 5. Anand K, Ensor J, Trachtenberg B, Bernicker EH. Osimertinib-Induced Cardiotoxicity: A Retrospective Review of the FDA Adverse Events Reporting System (FAERS). JACC CardioOncol. 2019; 1: 172-178.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Afatinib/osimertinib;Reactions Weekly;2024-07-20